PFIZER
|
PFIZER Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 120.51 | 136.38 | 133.89 | 108.77 | 111.29 |
| CEPS(Rs) | 134.12 | 159.44 | 159.03 | 132.68 | 133.85 |
| DPS(Rs) | 35.00 | 70.00 | 30.00 | 35.00 | 330.00 |
| Book NAV/Share(Rs) | 785.91 | 701.05 | 626.10 | 523.07 | 742.18 |
| Tax Rate(%) | 26.10 | 24.28 | 20.74 | 25.59 | 20.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.43 | 31.60 | 30.79 | 31.82 | 26.62 |
| EBIT Margin(%) | 32.88 | 32.71 | 28.86 | 30.56 | 30.37 |
| Pre Tax Margin(%) | 32.21 | 32.18 | 28.46 | 29.87 | 29.86 |
| PAT Margin (%) | 23.81 | 24.37 | 22.56 | 22.23 | 23.66 |
| Cash Profit Margin (%) | 26.49 | 28.49 | 26.79 | 27.12 | 28.46 |
| Performance Ratios | |||||
| ROA(%) | 13.65 | 16.09 | 17.24 | 13.00 | 12.20 |
| ROE(%) | 16.21 | 20.55 | 23.30 | 17.19 | 15.89 |
| ROCE(%) | 22.37 | 27.56 | 29.78 | 23.62 | 20.38 |
| Asset Turnover(x) | 0.57 | 0.66 | 0.76 | 0.58 | 0.52 |
| Sales/Fixed Asset(x) | 1.71 | 1.90 | 2.07 | 1.75 | 1.81 |
| Working Capital/Sales(x) | 1.06 | 1.39 | 1.80 | 2.04 | 1.01 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | 0.53 | 0.48 | 0.57 | 0.55 |
| Receivable days | 26.74 | 20.98 | 16.89 | 22.89 | 29.15 |
| Inventory Days | 67.09 | 61.77 | 59.41 | 70.57 | 69.32 |
| Payable days | 95.85 | 109.35 | 114.15 | 176.59 | 212.28 |
| Valuation Parameters | |||||
| PER(x) | 34.80 | 25.40 | 32.50 | 41.57 | 36.17 |
| PCE(x) | 31.27 | 21.73 | 27.36 | 34.08 | 30.07 |
| Price/Book(x) | 5.34 | 4.94 | 6.95 | 8.64 | 5.42 |
| Yield(%) | 0.83 | 2.02 | 0.69 | 0.77 | 8.20 |
| EV/Net Sales(x) | 7.82 | 5.77 | 7.00 | 8.74 | 7.53 |
| EV/Core EBITDA(x) | 21.01 | 15.37 | 20.33 | 24.67 | 21.40 |
| EV/EBIT(x) | 22.51 | 16.71 | 23.31 | 28.61 | 24.78 |
| EV/CE(x) | 4.76 | 4.36 | 4.74 | 6.02 | 4.77 |
| M Cap / Sales | 8.75 | 6.54 | 7.62 | 9.24 | 8.56 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -9.55 | -7.13 | 16.64 | 4.04 | 3.37 |
| Core EBITDA Growth(%) | -10.35 | 1.27 | 13.24 | 4.86 | 3.24 |
| EBIT Growth(%) | -9.07 | 6.88 | 14.54 | 4.68 | -1.23 |
| PAT Growth(%) | -11.64 | 1.86 | 23.10 | -2.26 | 18.66 |
| EPS Growth(%) | -11.64 | 1.86 | 23.10 | -2.26 | 18.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 5.01 | 3.79 | 2.77 | 2.42 | 3.45 |
| Quick Ratio(x) | 4.22 | 3.16 | 2.24 | 1.87 | 2.96 |
| Interest Cover(x) | 49.35 | 62.13 | 73.23 | 44.45 | 59.36 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹23,864.8 Cr | 0.2% | -5.1% | 28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
| CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.2% |
-5.1% |
28.7% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses
